Vortioxetine effects on quality of life of irritable bowel syndrome patients: A randomized, double‐blind, placebo‐controlled trial (original) (raw)
The use of psychotropic drugs in irritable bowel syndrome
Roy Dekel, Ami D Sperber
Expert Opinion on Investigational Drugs, 2013
View PDFchevron_right
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis
Lucinda Harris
The American Journal of Gastroenterology, 2019
View PDFchevron_right
Antidepressant therapy in 138 patients with irritable bowel syndrome: a five‐year clinical experience
David Alpers
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis
Shekoufeh Nikfar
World journal of …, 2009
View PDFchevron_right
Guidelines on the irritable bowel syndrome: mechanisms and practical management
Adepoju Paul Emmanuel
Gut, 2007
View PDFchevron_right
Paroxetine in Patients With Irritable Bowel Syndrome
Sanjay Gupta
The Primary Care Companion to The Journal of Clinical Psychiatry, 2002
View PDFchevron_right
History of Depressive and Anxiety Disorders and Paroxetine Response in Patients With Irritable Bowel Syndrome
Ashwin Patkar
The Primary Care Companion to The Journal of Clinical Psychiatry, 2008
View PDFchevron_right
The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment
Massimo Bellini
Journal of gastroenterology and hepatology, 2018
View PDFchevron_right
Significant psychological morbidity occurs in irritable bowel syndrome: a case-control study using a pharmacy reimbursement database
Colm O'Morain
Alimentary Pharmacology & Therapeutics, 2009
View PDFchevron_right
A Double-Blind, Randomized, Placebo-Controlled Trial of Paroxetine Controlled-Release in Irritable Bowel Syndrome
paolo mannelli
Psychosomatics, 2009
View PDFchevron_right
AGA technical review on irritable bowel syndrome
Douglas Drossman
Gastroenterology, 2002
View PDFchevron_right
Current and novel therapeutic options for irritable bowel syndrome management
Viola Andresen
Digestive and Liver Disease, 2009
View PDFchevron_right
Treatment of irritable bowel syndrome
Robin Spiller
Current Treatment Options in Gastroenterology, 2003
View PDFchevron_right
Systematic review of modulators of benzodiazepine receptors in irritable bowel syndrome: Is there hope?
Pooneh Salari
World Journal of Gastroenterology: WJG, 2011
View PDFchevron_right
American Gastroenterological Association Institute Technical Review on the Pharmacological Management of Irritable Bowel Syndrome
Luis Ramirez
View PDFchevron_right
Clinical trial: the effect of amitriptyline in patients with diarrhoea-predominant irritable bowel syndrome
N. Ghaffari, Reza Malekzadeh
Alimentary Pharmacology & Therapeutics, 2008
View PDFchevron_right
Review: Therapeutic advances in functional gastrointestinal disease: Irritable bowel syndrome
Braden Kuo
2009
View PDFchevron_right
Systematic review: The efficacy of treatments for irritable bowel syndrome - A European perspective
Julius Spicak
2006
View PDFchevron_right
Assesment of Psychiatric Symptoms and Co-morbidities in Patients with Irritable Bowel Syndrome
Cenk Ural
View PDFchevron_right
The effect of fluoxetine in patients with pain and constipation-predominant irritable bowel syndrome: a double-blind randomized-controlled study
homayoun vahedi
Alimentary Pharmacology and Therapeutics, 2005
View PDFchevron_right
Irritable bowel syndrome: A technical review for practice guideline development
Douglas Drossman
Gastroenterology, 1997
View PDFchevron_right
Irritable bowel syndrome: Epidemiology, diagnosis and treatment: An update for health-care practitioners
Saunjoo Yoon
2010
View PDFchevron_right
The treatment of irritable bowel syndrome
Robin Spiller, Murray Barclay
Alimentary Pharmacology and Therapeutics, 2002
View PDFchevron_right
Irritable bowel syndrome: Current treatment strategies
Konstantinos Triantafyllou
2007
View PDFchevron_right
Therapy options in irritable bowel syndrome
Paul Enck
European Journal of Gastroenterology & Hepatology, 2010
View PDFchevron_right
Psychiatric morbidity among patients with irritable bowel syndrome
Sultana Algin
Bangladesh Journal of Psychiatry, 2020
View PDFchevron_right
Psychiatric, Somatic and Other Functional Gastrointestinal Disorders in Patients With Irritable Bowel Syndrome at a Tertiary Care Center
prashant singh
Journal of Neurogastroenterology and Motility, 2012
View PDFchevron_right
Updates on treatment of irritable bowel syndrome
Christina Surawicz
2008
View PDFchevron_right
Citalopram Provides Little or No Benefit in Nondepressed Patients With Irritable Bowel Syndrome
Barbara Grimes
Clinical Gastroenterology and Hepatology, 2010
View PDFchevron_right
Recent advances in the treatment of irritable bowel syndrome
Mario Grassini
Polish archives of internal medicine, 2021
View PDFchevron_right
Open-Label Treatment With Citalopram in Patients With Irritable Bowel Syndrome
Sanjay Gupta
The Primary Care Companion to The Journal of Clinical Psychiatry, 2005
View PDFchevron_right